Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse.
about
A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersCost-benefit analysis of drug treatment services: review of the literature*Using administrative data for longitudinal substance abuse research.Cost-effectiveness of screening for unhealthy alcohol use with % carbohydrate deficient transferrin: results from a literature-based decision analytic computer model.Changes in health care costs over time following the cessation of intimate partner violence.Are alcohol-related acute surgical admission rates falling?Heroin purchasing is income and price sensitiveThe economic costs of quarterly monitoring and recovery management checkups for adults with chronic substance use disorders.Effects of naltrexone treatment for alcohol-related disorders on healthcare costs in an insured population.Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?A literature review of cost-benefit analyses for the treatment of alcohol dependence.Relay model for recruiting alcohol dependent patients in general hospitals--a single-blind pragmatic randomized trialThe effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington stateEffect of eliminating behavioral health benefits for selected medicaid enrollees.Utilization and cost of mental health, substance abuse, and medical services among at-risk drinkers.Gaps in clinical prevention and treatment for alcohol use disorders: costs, consequences, and strategies.Benefit-cost analysis of SBIRT interventions for substance using patients in emergency departments.The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use DisordersAlcohol Consumption and Inpatient Health Service Utilization in a Cohort of Patients With Alcohol Dependence After 20 Years of Follow-up.Medical Costs of Persons with Drug Use Disorders Among Medicaid Managed Care Beneficiaries in Puerto Rico : Comparison of the Direct Services Costs Incurred by Beneficiaries With and Without a Drug Use Disorder.Evaluation of an innovative Medicaid health policy initiative to expand substance abuse treatment in Washington State.Treatment outcome and its predictors among Asian problem drinkers.Demand for prior treatment in alcoholic patients.The cost-effectiveness of therapies to treat alcohol use disorders.People with alcohol use disorders in specialized care in eight different European countries.Organization and financing of alcohol and substance abuse programs for American Indians and Alaska Natives.Cost-utility analysis of methadone maintenance treatment: a methodological approach.
P2860
Q27000732-CAFEBE74-1166-40C4-8129-5908E0678E4AQ30729913-CDB1D936-D55C-4DEF-81A6-ADA995F512B9Q31168666-77E9620E-880F-49AB-BF88-7490BFD62EDFQ33441704-04D95744-9A15-46DD-ABD0-35B4BAFCC1B2Q34050765-939F8674-0096-4AFA-8752-28A68A903D6FQ34125616-63F3B8AD-8E0A-4C50-9508-C99B91E4A7F6Q35046416-15BAA130-E8C0-4FEF-A59A-653FB6ECC9D4Q35129706-56A059AF-1510-4F89-9CC3-327002AA395BQ35175340-B8F0AACD-6A32-4B2C-A881-05C74DD7A3D4Q35193555-8C1DA854-C4C0-445E-A765-E0212273A52EQ35195707-7A35BB23-A285-4098-9DDA-B55F3B2ACB4BQ35990659-7A562F58-E949-499E-AC2F-F2341F14FA53Q36585906-65C4D638-E35B-45B7-B558-5971258EA8D5Q36839716-DF2678FA-3099-451E-B63B-957DCBAF997FQ36904106-E7164933-2A9F-491F-BB26-14DCC066F16CQ37537442-29A03549-999E-44D7-8C5F-B90F92A0E52DQ38695666-18424BB2-D789-486B-B5DE-947BAC45701CQ38950639-AB7EE70B-E455-4F63-A7F9-C145BF349E77Q38969926-A615259F-CF35-4924-B73B-AB262E4307AEQ40685864-ECDC643D-95CE-4FB5-A948-EA377C6CFFD3Q44965777-4215AC7B-8061-4FAA-88F9-09749FE5E0BBQ46618759-0C7031D4-DDF8-45E9-AEFF-E8B3757BECADQ46879902-0A25523B-488C-46F4-839B-16D3C9FAF9DDQ47599832-21D92802-8D10-4AB8-819A-F4B521E3AAF7Q47739984-9856FF6F-46C5-4515-93D3-C98F4D15903FQ51915465-CF5B407C-FBBF-4590-9399-BEB4E8F34DEAQ53263270-FD077B99-00FC-409C-B0C3-ED668E79E9A0
P2860
Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cost benefits of substance abu ...... s from alcohol and drug abuse.
@ast
Cost benefits of substance abu ...... s from alcohol and drug abuse.
@en
Cost benefits of substance abu ...... s from alcohol and drug abuse.
@nl
type
label
Cost benefits of substance abu ...... s from alcohol and drug abuse.
@ast
Cost benefits of substance abu ...... s from alcohol and drug abuse.
@en
Cost benefits of substance abu ...... s from alcohol and drug abuse.
@nl
prefLabel
Cost benefits of substance abu ...... s from alcohol and drug abuse.
@ast
Cost benefits of substance abu ...... s from alcohol and drug abuse.
@en
Cost benefits of substance abu ...... s from alcohol and drug abuse.
@nl
P1476
Cost benefits of substance abu ...... s from alcohol and drug abuse.
@en
P2093
Harold D. Holder
P356
10.1002/(SICI)1099-176X(199803)1:1<23::AID-MHP3>3.0.CO;2-Q
P577
1998-03-01T00:00:00Z